<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04744896</url>
  </required_header>
  <id_info>
    <org_study_id>EHCIBPP</org_study_id>
    <nct_id>NCT04744896</nct_id>
  </id_info>
  <brief_title>Effects Of Combined Cryolipolysis And High Intensity Interval Training On Insulin Resistance And Body Composition In Polycystic Ovarian Patients</brief_title>
  <official_title>Effects Of Combined Cryolipolysis And High Intensity Interval Training On Insulin Resistance And Body Composition In Polycystic Ovarian Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      this study will be carried to investigate the effect of cryolipolysis and high intensity&#xD;
      interval training on insulin resistance and body composition in pco women&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be carried out on ninety females with polycystic ovarian syndrome (PCOS)l.&#xD;
      Their age ranges from 17-28 years, body mass index 25-30 Kg/m2. They experience&#xD;
      hyperandrogenism and hyperinsulinemia.&#xD;
&#xD;
      PCOS females will be randomly assigned into three equal groups: group (A) consists of 30&#xD;
      women who receive cryolipolysis and group (B) consists of 30 women who receive high intensity&#xD;
      interval training and group (C) receive both&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>cryolipolysis treadmill cryolipolysis + treadmill</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HOMA IR</measure>
    <time_frame>3 months</time_frame>
    <description>blood test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>weight</measure>
    <time_frame>up to 3 months</time_frame>
    <description>anthropometric measure measured in kilogram (kg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fat percentage</measure>
    <time_frame>up to 3 months</time_frame>
    <description>overall body fat percentage measured by body fat analyzer in percentage (%)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>waist circumference</measure>
    <time_frame>up to 3 months</time_frame>
    <description>anthropometric measurement measured in centimeter (cm)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <condition>Hyperinsulinism</condition>
  <arm_group>
    <arm_group_label>cryolipolysis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3max cool shaping device is administered 3 times for each patient, one session every 6 weeks, each session is 40 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>treadmill</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>aerobic training in form of high intensity interval training, three times per week for 3 weeks by treadmill(jkexer focus 8020A) each session is for 20 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>treadmill+cryolipolysis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>aerobic training 3 times per week and cryolipolysis once every 6 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cryolipolysis(3 max cool shaping)</intervention_name>
    <description>cryolioplysis applied over abdomen area</description>
    <arm_group_label>cryolipolysis</arm_group_label>
    <arm_group_label>treadmill+cryolipolysis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Treadmill (jkexer focus 8020A)</intervention_name>
    <description>aerobic training ( high intensity interval training)</description>
    <arm_group_label>treadmill</arm_group_label>
    <arm_group_label>treadmill+cryolipolysis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  women diagnosed with polycystic ovarian syndrome&#xD;
&#xD;
          -  age ranges from 17-28 years&#xD;
&#xD;
          -  body mass index ranges 25-30 Kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diabetic patients.&#xD;
&#xD;
          -  Women with BMI&gt;30&#xD;
&#xD;
          -  Women having circulatory dysfunction.&#xD;
&#xD;
          -  Women with respiratory or cardiac disease&#xD;
&#xD;
          -  liver disease.&#xD;
&#xD;
          -  Skin disease .&#xD;
&#xD;
          -  Previous abdominal or uterine surgery&#xD;
&#xD;
          -  any medications affecting hormones&#xD;
&#xD;
          -  any physical impairments&#xD;
&#xD;
          -  Physical impairment&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>28 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>amal mo youssef, phd</last_name>
    <role>Study Director</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>miral saleh, md</last_name>
    <phone>01200678845</phone>
    <phone_ext>+010</phone_ext>
    <email>marmooramido@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <state>Giza</state>
        <zip>11865</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>miral s mohamed, md</last_name>
      <phone>01200678845</phone>
      <phone_ext>+012</phone_ext>
      <email>marmooramido@gmail.com</email>
    </contact>
    <investigator>
      <last_name>fahema me okiel, phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 3, 2021</study_first_submitted>
  <study_first_submitted_qc>February 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 9, 2021</study_first_posted>
  <last_update_submitted>February 21, 2021</last_update_submitted>
  <last_update_submitted_qc>February 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Miral Saleh Mohamed</investigator_full_name>
    <investigator_title>assistant lecturer</investigator_title>
  </responsible_party>
  <keyword>pco</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Hyperinsulinism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

